Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
33.73
+0.68 (2.06%)
Mar 4, 2026, 1:58 PM EST - Market open
Galapagos NV Revenue
In the year 2025, Galapagos NV had annual revenue of 1.11B EUR with 303.48% growth. Galapagos NV had revenue of 900.77M in the quarter ending December 31, 2025, with 1,093.16% growth.
Revenue (ttm)
1.11B EUR
Revenue Growth
+303.48%
P/S Ratio
1.68
Revenue / Employee
1,993,190 EUR
Employees
558
Market Cap
2.19B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.11B | 836.55M | 303.48% |
| Dec 31, 2024 | 275.65M | 35.93M | 14.99% |
| Dec 31, 2023 | 239.72M | -1.53M | -0.63% |
| Dec 31, 2022 | 241.25M | 6.87M | 2.93% |
| Dec 31, 2021 | 234.38M | -243.67M | -50.97% |
| Dec 31, 2020 | 478.05M | -356.85M | -42.74% |
| Dec 31, 2019 | 834.90M | 556.24M | 199.61% |
| Dec 31, 2018 | 278.67M | 151.58M | 119.27% |
| Dec 31, 2017 | 127.09M | -2.43M | -1.88% |
| Dec 31, 2016 | 129.52M | 89.96M | 227.37% |
| Dec 31, 2015 | 39.56M | -29.81M | -42.97% |
| Dec 31, 2014 | 69.37M | -7.26M | -9.47% |
| Dec 31, 2013 | 76.63M | -59.64M | -43.77% |
| Dec 31, 2012 | 136.27M | 42.80M | 45.79% |
| Dec 31, 2011 | 93.47M | -20.67M | -18.11% |
| Dec 31, 2010 | 114.14M | 21.05M | 22.62% |
| Dec 31, 2009 | 93.09M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Telix Pharmaceuticals | 803.79M |
| Ultragenyx Pharmaceutical | 673.00M |
| Zai Lab | 460.16M |
| Stoke Therapeutics | 205.63M |
| Soleno Therapeutics | 190.41M |
| Ascentage Pharma Group International | 54.52M |
| Ocular Therapeutix | 51.95M |
| Immunome | 9.68M |
GLPG News
- 1 day ago - Galapagos NV at TD Cowen Healthcare Conference Transcript - GuruFocus
- 6 days ago - Galapagos FY25: Profits Not Built On Product - Seeking Alpha
- 7 days ago - GLPG: RBC Capital Raises Price Target, Reaffirms Sector Perform | GLPG Stock News - GuruFocus
- 8 days ago - Galapagos NV (GLPG) Full Year 2025 Earnings Call Highlights: Strategic Shifts and Financial ... - GuruFocus
- 8 days ago - Galapagos NV (GLPG) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Full Year 2025 Galapagos NV Earnings Call Transcript - GuruFocus
- 8 days ago - Galapagos GAAP EPS of €4.87, revenue of €1.11B; introduces Q1 and FY26 outlook - Seeking Alpha
- 8 days ago - Earnings Breakdown: Galapagos Q4 - Benzinga